Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Draegerwerk AG & Co. KGaA (DE:DRW3)
XETRA:DRW3
RESEARCH TOOLSreports
Holding DE:DRW3?
Track your performance easily
DRW3 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€43.10 - €56.20
Previous Close€45.25
Volume252.00
Average Volume (3M)6.59K
Market Cap
€805.60M
Enterprise Value€877.62M
Total Cash (Recent Filing)€306.67M
Total Debt (Recent Filing)€361.95M
Price to Earnings (P/E)7.2
Beta0.46
Next Earnings
Apr 03, 2025EPS Estimate
€6.28Last Dividend Ex-Date
May 09, 2024Dividend Yield4.02%
Share Statistics
EPS (TTM)6.20
Shares OutstandingN/A
10 Day Avg. Volume6,078
30 Day Avg. Volume6,586
Standard Deviation0.10
R-Squared0.08
Alpha0.00252
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.25
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€60.75Price Target Upside36.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Improved EBIT MarginThe Q2 EBIT margin improved significantly to 5.2%, reflecting positive one-off contributions.
Net Sales IncreaseDräger saw an increase in net sales of 1.7%, driven by a strong safety division.
Optimistic EBIT OutlookDräger has become more optimistic and now expects an EBIT margin in the upper half of the guidance.
Bears Say
Analyst RatingUnderperform rating remains unchanged.
Client BehaviorCost pressure for hospitals causes clients to more frequently opt for larger suppliers.
CompetitionLarger suppliers offer more economically priced packages with a better patient monitoring offering.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
10.16% Mutual Funds
― Other Institutional Investors
85.32% Public Companies and
Individual Investors
DRW3 FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
Draegerwerk AG & Co. KGaA lowest stock price was €43.10 and its highest was €56.20 in the past 12 months.
What is Draegerwerk AG & Co. KGaA’s market cap?
Currently, no data Available
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
Draegerwerk AG & Co. KGaA’s upcoming earnings report date is Apr 03, 2025 which is in 146 days.
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Currently, no data Available
Is Draegerwerk AG & Co. KGaA overvalued?
According to Wall Street analysts Draegerwerk AG & Co. KGaA’s price is currently Undervalued.
Does Draegerwerk AG & Co. KGaA pay dividends?
Draegerwerk AG & Co. KGaA pays a Annually dividend of €1.8 which represents an annual dividend yield of 4.02%. See more information on Draegerwerk AG & Co. KGaA dividends here
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
Draegerwerk AG & Co. KGaA’s EPS estimate is €6.28.
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
Draegerwerk AG & Co. KGaA has 8,600,000 shares outstanding.
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:DRW3
---
Draegerwerk AG & Co. KGaA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€60.75 (36.36% Upside)
€60.75 (36.36% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.55%
12-Months-Change
Fundamentals
Return on Equity
8.37%
Trailing 12-Months
Asset Growth
1.84%
Trailing 12-Months
Company Description
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two divisions: medical and safety. The medical division contributes the majority of revenue. It sells anesthesia workstations, ventilators for intensive care, patient monitoring solutions, and neonatal care equipment to hospitals. The safety division sells respiratory protection equipment, stationary and mobile gas detection systems, professional diving systems, and alcohol and drug testing devices for emergency response, law and regulatory enforcement, and industrial customers. Draegerwerk generates the majority of its revenue in Europe.
---
DRW3 Stock 12 Month Forecast
Average Price Target
€60.75
▲(36.36% Upside)
Technical Analysis
Smith & Nephew
―
GlaxoSmithKline
―
AstraZeneca
―
Hikma Pharmaceuticals
―
Draegerwerk AG & Co. KGaA
―
Best Analysts Covering DRW3
1 Year
1 Year Success Rate
3/20 ratings generated profit
1 Year Average Return
-11.05%
reiterated a buy rating 11 days ago
Copying Alexander Galitsa's trades and holding each position for 1 Year would result in 15.00% of your transactions generating a profit, with an average return of -11.05% per trade.
---